| Literature DB >> 35205325 |
Feng Leng1,2, Yue Wang1, Jinping Cao1, Shiping Wang3, Di Wu1, Ling Jiang4, Xian Li1, Jinsong Bao5, Naymul Karim6, Chongde Sun1.
Abstract
Root restriction (RR) has been reported to enhance grape berry quality in diverse aspects of grape life. In this study, RR-induced increases in the main primary metabolites in the grape berry and the expression of their related genes were studied at different developmental stages. Mainly the transcriptomic and metabolomic level were analyzed using 'Summer Black' grape berry as a material. The main results were as follows: A total of 11 transcripts involved in the primary metabolic pathways were significantly changed by the RR treatment. Metabolites such as sugars, organic acids, amino acids, starch, pectin, and cellulose were qualitatively and quantitatively analyzed along with their metabolic pathways. Sucrose synthase (VIT_07s0005g00750, VIT_11s0016g00470) and sucrose phosphate synthase (VIT_18s0089g00410) were inferred to play critical roles in the accumulation of starch, sucrose, glucose, and fructose, which was induced by the RR treatment. RR treatment also promoted the malic acid and tartaric acid accumulation in the young berry. In addition, the grape berries after the RR treatment tended to have lower pectin and cellulose content.Entities:
Keywords: RNA-Seq; grape berry; primary metabolites; root restriction
Mesh:
Substances:
Year: 2022 PMID: 35205325 PMCID: PMC8872613 DOI: 10.3390/genes13020281
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Primers for real-time PCR.
| Gene | Forward Primer (5’ to 3’) | Reverse Primer (5’ to 3’) |
|---|---|---|
|
| TGGAGCTGAATTTGTTGT | GTGGAGTTCTGGCTTGTA |
|
| ACTACCAACTGTCTTGCTCCTCTG | AGTAAGGTCCACGACTGAAACATC |
|
| CCTCAACGCCAACATTAG | GCCAAACCAGACCCTACT |
|
| GATGTAGGGCGGCAGAAACT | GAACAGCAATAGCCACAAAAGG |
|
| ACTGCTGTTGGGTCTGGC | GAGGGCGTATCGGTCTTG |
|
| AAACACCCTCCCACCTAC | TATCCTTCGCCCTACTCC |
Differentially expressed genes in the primary metabolic pathways under RR treatment during grape development (FDR < 0.05 and Log2|FC| > 1). FDR, false discovery rate; FC, fold change.
| Gene ID | Log2FC | Functional Annotation | ||||
|---|---|---|---|---|---|---|
| S1RR/ | S2RR/ | S3RR/ | S4RR/ | S5RR/ | ||
|
| 1.44 | - | - | - | - | UDP-glucose 6-dehydrogenase |
|
| 1.50 | 1.95 | - | - | - | glyceraldehyde 3-phosphate dehydrogenase |
|
| 1.69 | - | - | - | - | sucrose synthase |
|
| −1.33 | - | - | - | - | sucrose synthase |
|
| - | - | - | 1.55 | - | sucrose-phosphate synthase |
|
| - | - | - | 1.30 | - | 3-deoxy-7-phosphoheptulonate synthase |
|
| 1.93 | - | −1.60 | - | - | branched-chain amino acid aminotransferase |
|
| −1.17 | - | - | - | - | alpha-trehalase |
|
| −1.03 | - | - | - | - | aconitate hydratase |
|
| 1.30 | - | - | - | - | enolase |
|
| 1.32 | 2.25 | - | - | - | asparagine synthase |
Figure 1Effects of RR treatment on the content change of sugars and organic acids of the grape berry. (A) Citric; (B) glucose; (C) malic; (D) fructose; (E) tartaric; (F) sucrose. * indicates significant differences (p < 0.05, n = 3).
Figure 2Effects of RR treatment on the content change of amino acids of grape berry. (A) Valine; (B) serine; (C) threonine; (D) proline; (E) aspartic acid; (F) phenylalanine; (G) glutamine. * indicates significant differences (p < 0.05, n = 3).
Figure 3Effects of RR treatment on the content change of starch, pectin, and cellulose of grape berry. (A) Soluble pectin; (B) starch; (C) protopectin; (D) cellulose. * indicates significant differences (p < 0.05, n = 3).
Figure 4qRT-PCR validation of the transcripts between two treatments of grape berries during development and ripening..Correlation of fold change was analyzed by RNA-Seq (x axis) and the data were obtained using qRT-PCR (y axis).
Figure 5Effects of RR treatment on the primary metabolic pathways in grape berry. Boxes corresponding with the berry development process, from left to right, were obtained by using the MultiExperiment Viewer software. The dataset was normalized to the values in control treatment at the stages before veraison via log2 transformation. The relative expression changes at the RR treatment and other stages in relation to the stages before veraison in control treatment were expressed as log2 fold changes. The upper set of boxes was for the control treatment and the lower set was for the RR treatment. thrA, bifunctional aspartokinase/homoserine dehydrogenase 1; UGDH, UDP-glucose 6-dehydrogenase; MDH1, malate dehydrogenase; IDH1, isocitrate dehydrogenase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; SDHA, succinate dehydrogenase flavoprotein subunit; E1.4.7.1, glutamate synthase; proC, pyrroline-5-carboxylate reductase; DLAT, dihydrolipoamide acetyltransferase; CS, citrate synthase; ACLY, ATP citrate lyase; E2.4.1.14, sucrose phosphate synthase; glgB, 1,4-alpha-glucan branching enzyme; glgA, starch synthase; GAUT, alpha-1,4-galacturonosyltransferase; aroF, 3-deoxy-7-phosphoheptulonate synthase; GOT1, aspartate aminotransferase; ilvE, branched-chain amino acid aminotransferase; serC, phosphoserine aminotransferase; HK, hexokinase; PK, pyruvate kinase; glgC, glucose-1-phosphate adenylyltransferase; serB, phosphoserine phosphatase; treA, alpha-trehalase; ENPP1_3, ectonucleotide pyrophosphatase/phosphodiesterase family member 1/3; ALDO, fructose-bisphosphate aldolase; fumC, fumarate hydratase; ACO, aconitate hydratase; ENO, enolase; ADT, arogenate dehydratase; thrC, threonine synthase; aroB, 3-dehydroquinate synthase; E5.1.3.6, UDP-glucuronate 4-epimerase; GPI, glucose-6-phosphate isomerase; glnA, glutamine synthetase; ASNS, asparagine synthase.